Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-908662 +/- Cetuximab in Advanced Colorectal Cancer
NCT01086267Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BMS-908662 in colorectal cancer (CRC), sponsored by Bristol Myers Squibb. Started Jul 2010; status: completed.
02
Drugs
BMS-908662
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01086267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086267.